Medigene

08.03.2022 • News

BioNTech and Medigene Collaborate on Cancer Therapy

Two German biotechs, RNA vaccines specialist BioNTech and Medigene, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, have entered a three-year multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer.

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.